Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDFT1 | P37268 | 2/20 | 0.53 |
| ▸ | PPARA | Q07869 | 7/20 | 0.51 |
| ▸ | PPARG | P37231 | 5/20 | 0.51 |
| ▸ | LPL | P06858 | 2/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.45 |
| ▸ | CETP | P11597 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10106216 | 0.92 | PPARA (0.52) | FDFT1PPARAPPARGLPLLIPG | |
| SCHEMBL10106190 | 0.88 | FDFT1 (0.53) | FDFT1PPARAPPARGLPLLIPG | |
| SCHEMBL28547948 | 0.87 | PPARA (0.63) | PPARAPPARGLPLLIPGCETP | |
| SCHEMBL176242 | 0.87 | PPARA (0.63) | PPARAPPARGLPLLIPGCETP | |
| SCHEMBL29693068 | 0.87 | PPARA (0.63) | PPARAPPARGLPLLIPGCETP | |
| SCHEMBL9819438 | 0.87 | PPARA (0.63) | PPARAPPARGLPLLIPGCETP | |
| SCHEMBL27830388 | 0.87 | PPARA (0.63) | PPARAPPARGLPLLIPGCETP | |
| SCHEMBL9303918 | 0.85 | PPARA (0.61) | PPARAPPARGLPLLIPGCETP | |
| SCHEMBL10106193 | 0.84 | PPARA (0.60) | FDFT1PPARAPPARGCETP | |
| SCHEMBL10106192 | 0.84 | FDFT1 (0.54) | FDFT1PPARAPPARGLPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120022024-A1 | ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022024-A1 | ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS | CUTA, MMP8, CLPP | FDFT1 1987/4885PPARA 3798/4885PPARG 4092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.